Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Squamous cell carcinoma of esophagus
0.080 Biomarker disease BEFREE A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma. 30876762 2019
Squamous cell carcinoma of esophagus
0.080 AlteredExpression disease BEFREE Enforced PLK1 expression in ESCC cells not only markedly rescued cells from plumbagin-induced apoptosis and proliferation inhibition but also restored the impaired AKT activity. 29339720 2018
Squamous cell carcinoma of esophagus
0.080 Biomarker disease BEFREE Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma. 29959473 2018
Squamous cell carcinoma of esophagus
0.080 AlteredExpression disease BEFREE The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma. 29679654 2018
Squamous cell carcinoma of esophagus
0.080 AlteredExpression disease BEFREE Furthermore, phosphorylation of Stat3 and overexpression of PLK1 were correlated in a subset of ESCC. 22108192 2012
Squamous cell carcinoma of esophagus
0.080 AlteredExpression disease BEFREE In addition, RelA gene amplification and protein overexpression was significantly correlated with PLK1 expression in ESCC tissues. 21610149 2011
Squamous cell carcinoma of esophagus
0.080 AlteredExpression disease BEFREE Our results show that Plk1 expression is elevated in ESCC tissues and is associated with differentiation grades and invasiveness in ESCC, indicating that overexpression of Plk1 may play an important role in carcinogenesis and malignant progress of ESCC. 19572149 2010
Squamous cell carcinoma of esophagus
0.080 Biomarker disease BEFREE These data suggest that PLK1 might be a useful prognostic marker and a potential therapeutic target for ESCC. 19004025 2009